Founded 2018, subsidiary of Social Investment Scotland. Portfolio: 16-28 companies (Dxcover, Manus Neurodynamica, Nami Surgical, Solasta Bio, Beta Bugs, Good Loop, Cyacomb, Trojan Energy). Team 10-13. Value-add: proprietary impact mgmt framework, governance support, extensive network. Recent: 6 investments in 2024. NOW CLOSED to new investments; portfolio mgmt phase.
Investment Focus
Investment Thesis
Impact-first seed to Series A, Scotland-based. Dual-return strategy: financial + measurable social/environmental impact aligned to UN SDGs. Sectors: life sciences, agtech, clean tech, healthcare tech. Check sizes £100k-£500k (rounds £500k-£3m). Mission-lock mechanism embedded in Articles of Association. FCA-regulated. Avoids: new investments currently (portfolio mgmt focused). Team: 13 incl. 8 partners.
Interested in connecting?
Visit their website or reach out directly.